Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - KERYX BIOPHARMACEUTICALS INCFinancial_Report.xls
10-K - FORM 10-K - KERYX BIOPHARMACEUTICALS INCv302731_10k.htm
EX-31.2 - EXHIBIT 31.2 - KERYX BIOPHARMACEUTICALS INCv302731_ex31-2.htm
EX-21.1 - EXHIBIT 21.1 - KERYX BIOPHARMACEUTICALS INCv302731_ex21-1.htm
EX-31.1 - EXHIBIT 31.1 - KERYX BIOPHARMACEUTICALS INCv302731_ex31-1.htm
EX-32.1 - EXHIBIT 32.1 - KERYX BIOPHARMACEUTICALS INCv302731_ex32-1.htm
EX-32.2 - EXHIBIT 32.2 - KERYX BIOPHARMACEUTICALS INCv302731_ex32-2.htm
EX-10.20 - EXHIBIT 10.20 - KERYX BIOPHARMACEUTICALS INCv302731_ex10-20.htm

 

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

 

The Board of Directors

Keryx Biopharmaceuticals, Inc.:

 

We consent to the incorporation by reference in the following registration statements of Keryx Biopharmaceuticals, Inc. of our report dated March 2, 2012, with respect to the consolidated balance sheets of Keryx Biopharmaceuticals, Inc. (the “Company”) as of December 31, 2011 and 2010, and the related consolidated statements of operations, stockholders’ equity and comprehensive loss (income), and cash flows for the years ended December 31, 2011, 2010 and 2009, which report appears in the December 31, 2011 annual report on Form 10-K of the Company:

 

-Form S-8 dated February 5, 2001 (File No. 333-55006)
-Form S-8 dated September 29, 2004 (File No. 333-119377)
-Form S-8 dated April 6, 2006, as amended (File No. 333-133052)
-Form S-8 dated July 31, 2007 (File No. 333-145003)
-Form S-3 dated August 28, 2009 (File No. 333-161607)
-Form S-8 dated March 25, 2010 (File No. 333-165710)
-Form S-3 dated January 3, 2011 (File No. 333-171517)

 

/s/ UHY LLP  
   
New York, New York  
March 2, 2012